RESMED INC — Director's Dealing 2015

Nov 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-13

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-13	ResMed Common Stock	D	28000	$57.00	Disposed	149327.132	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $57.00 to $57.14. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F2: Includes 188.795 shares of stock purchased on October 30, 2015, through ResMed's Employee Stock Purchase Plan.